Contact
searchSearch
HMP Global

Featured Topics

Type 2 Inflammation Learning Library

Featured Video

Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research...
03/15/2025
APP Institute Dermatology

Atopic dermatitis
Quiz
Barrier Repair & Inflammation Control in Atopic Dermatitis
03/23/2025
Riya Gandhi, MA
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how...
03/23/2025
APP Institute Dermatology
Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research...
03/15/2025
APP Institute Dermatology
Rash
Quiz
Environmental Triggers of Barrier Damage & Type 2 Inflammation
03/12/2025
Riya Gandhi, MA
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how...
03/12/2025
APP Institute Dermatology
telemedicine
News
Type 2 Inflammation and Fibrotic Pathways Drive Localized Scleroderma
02/24/2025
Riya Gandhi, MA
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct...
02/24/2025
APP Institute Dermatology
contact dermtitis + Neck + Eczema + rash
News
Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis
02/14/2025
Riya Gandhi, MA
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad...
02/14/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Environmental Impact on Atopy
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
APP Institute Dermatology
Atopic dermatitis
Quiz
Understanding Type 2 Inflammation: Pathways and Treatment Options
02/07/2025
Riya Gandhi, MA
Test your knowledge of type 2 Inflammation and your understanding of its pathways and treatment options.
Test your knowledge of type 2 Inflammation and your understanding of its pathways and treatment options.
Test your knowledge of type 2...
02/07/2025
APP Institute Dermatology
SOC
News
Immune Triggers Linked to Chronic Pruritus and Elevated Type 2 Inflammation
01/29/2025
Riya Gandhi, MA
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of...
01/29/2025
APP Institute Dermatology
Atopic dermatitis
News
Dupilumab Linked to Lower Risk of Upper Respiratory Infections in Patients With Atopic Dermatitis
01/17/2025
Riya Gandhi, MA
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Steven Feldman
Rapid Refresh
Type 2 Inflammation in Atopic Dermatitis
01/13/2025
Steven R. Feldman, MD, PhD
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology
Joy Wan
Clinical Pearls
Proactive Therapy for AD
04/05/2025
Joy Wan, MD, MSCE, FAAD
Proactive therapy for atopic dermatitis focuses on maintaining remission by addressing subclinical inflammation, even after visible symptoms subside.
Proactive therapy for atopic dermatitis focuses on maintaining remission by addressing subclinical inflammation, even after visible symptoms subside.
Proactive therapy for atopic...
04/05/2025
APP Institute Dermatology
Atopic dermatitis
Quiz
Barrier Repair & Inflammation Control in Atopic Dermatitis
03/23/2025
Riya Gandhi, MA
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how...
03/23/2025
APP Institute Dermatology
Ted Lain
Rapid Refresh
Pathogenesis Mechanism of Actinic Keratosis
03/20/2025
Ted Lain, MD
UV radiation is the primary driver of actinic keratoses and squamous cell carcinoma development, triggering DNA damage, lipid oxidation, inflammation, and immunosuppression—ultimately leading to keratinocyte tumor growth.
UV radiation is the primary driver of actinic keratoses and squamous cell carcinoma development, triggering DNA damage, lipid oxidation, inflammation, and immunosuppression—ultimately leading to keratinocyte tumor growth.
UV radiation is the primary...
03/20/2025
APP Institute Dermatology
Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research...
03/15/2025
APP Institute Dermatology
Rash
Quiz
Environmental Triggers of Barrier Damage & Type 2 Inflammation
03/12/2025
Riya Gandhi, MA
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how...
03/12/2025
APP Institute Dermatology
Jeffrey M. Cohen, MD
Clinical Pearls
Congestive Heart Failure and Psoriasis
03/10/2025
Jeffrey M. Cohen, MD
Dr Cohen explores the epidemiologic link between psoriasis and congestive heart failure (CHF), emphasizing the potential risks of TNF-alpha inhibitors in these patients.
Dr Cohen explores the epidemiologic link between psoriasis and congestive heart failure (CHF), emphasizing the potential risks of TNF-alpha inhibitors in these patients.
Dr Cohen explores the...
03/10/2025
APP Institute Dermatology
telemedicine
News
Type 2 Inflammation and Fibrotic Pathways Drive Localized Scleroderma
02/24/2025
Riya Gandhi, MA
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct...
02/24/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Why Alternative Medicine?
02/18/2025
Peter Lio, MD, FAAD
While some clinicians dismiss alternative medicine, patient interest underscores its relevance.
While some clinicians dismiss alternative medicine, patient interest underscores its relevance.
While some clinicians dismiss...
02/18/2025
APP Institute Dermatology
contact dermtitis + Neck + Eczema + rash
News
Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis
02/14/2025
Riya Gandhi, MA
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad...
02/14/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Environmental Impact on Atopy
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
APP Institute Dermatology

Videos

Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research...
03/15/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Environmental Impact on Atopy
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
APP Institute Dermatology
Steven Feldman
Rapid Refresh
Type 2 Inflammation in Atopic Dermatitis
01/13/2025
Steven R. Feldman, MD, PhD
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology
Gil Yosipovitch, MD,
Clinical Pearls
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
Gil Yosipovitch, MD
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology
Brian Kim, MD
Rapid Refresh
Itch Disorders
08/14/2024
Brian Kim, MD, MTR, FAAD
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch disorders with Dr Brian Kim.
Boost your knowledge of itch...
08/14/2024
APP Institute Dermatology
Joy Wan
Clinical Pearls
Proactive Therapy for AD
04/05/2025
Joy Wan, MD, MSCE, FAAD
Proactive therapy for atopic dermatitis focuses on maintaining remission by addressing subclinical inflammation, even after visible symptoms subside.
Proactive therapy for atopic dermatitis focuses on maintaining remission by addressing subclinical inflammation, even after visible symptoms subside.
Proactive therapy for atopic...
04/05/2025
APP Institute Dermatology
Ted Lain
Rapid Refresh
Pathogenesis Mechanism of Actinic Keratosis
03/20/2025
Ted Lain, MD
UV radiation is the primary driver of actinic keratoses and squamous cell carcinoma development, triggering DNA damage, lipid oxidation, inflammation, and immunosuppression—ultimately leading to keratinocyte tumor growth.
UV radiation is the primary driver of actinic keratoses and squamous cell carcinoma development, triggering DNA damage, lipid oxidation, inflammation, and immunosuppression—ultimately leading to keratinocyte tumor growth.
UV radiation is the primary...
03/20/2025
APP Institute Dermatology
Lauren McGrath
Clinical Pearls
Topical Treatments for Type 2 Inflammation
03/15/2025
Lauren McGrath
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research fellow for the Center for Dermatology Research and Center for Translational Dermatology in the department of dermatology at Wake Forest University School of Medicine.
Lauren McGrath is a research...
03/15/2025
APP Institute Dermatology
Jeffrey M. Cohen, MD
Clinical Pearls
Congestive Heart Failure and Psoriasis
03/10/2025
Jeffrey M. Cohen, MD
Dr Cohen explores the epidemiologic link between psoriasis and congestive heart failure (CHF), emphasizing the potential risks of TNF-alpha inhibitors in these patients.
Dr Cohen explores the epidemiologic link between psoriasis and congestive heart failure (CHF), emphasizing the potential risks of TNF-alpha inhibitors in these patients.
Dr Cohen explores the...
03/10/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Why Alternative Medicine?
02/18/2025
Peter Lio, MD, FAAD
While some clinicians dismiss alternative medicine, patient interest underscores its relevance.
While some clinicians dismiss alternative medicine, patient interest underscores its relevance.
While some clinicians dismiss...
02/18/2025
APP Institute Dermatology
Peter Lio
Clinical Pearls
Environmental Impact on Atopy
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
APP Institute Dermatology
Matthew Zirwas, MD
Clinical Pearls
How to Ask About Itch
02/04/2025
Matthew J. Zirwas, MD
Traditional itch scales like the Peak Pruritus Numerical Rating Scale offer limited clinical value as single-day snapshots. Instead, dermatologists advocate for functional assessments, focusing on how itch impacts daily activities and sleep.
Traditional itch scales like the Peak Pruritus Numerical Rating Scale offer limited clinical value as single-day snapshots. Instead, dermatologists advocate for functional assessments, focusing on how itch impacts daily activities and sleep.
Traditional itch scales like the...
02/04/2025
APP Institute Dermatology
Steven Feldman
Rapid Refresh
Type 2 Inflammation in Atopic Dermatitis
01/13/2025
Steven R. Feldman, MD, PhD
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the role of type 2 inflammation in conditions like atopic dermatitis, asthma, and eosinophilic esophagitis.
Dr Steve Feldman discusses the...
01/13/2025
APP Institute Dermatology
Joy Wan
Clinical Pearls
Systemic Therapies for AD
01/10/2025
Joy Wan, MD, MSCE, FAAD
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic treatments for atopic dermatitis, from traditional options to modern biologics and JAK inhibitors, focusing on benefits, risks, and personalized care.
An overview of systemic...
01/10/2025
APP Institute Dermatology
Gil Yosipovitch, MD,
Clinical Pearls
Dupilumab for Adults With Prurigo Nodularis: A Critical Review
11/14/2024
Gil Yosipovitch, MD
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil Yosipovitch, MD, shares his expert insights into dupilumab for adult patients with prurigo nodularis.
In this feature interview, Gil...
11/14/2024
APP Institute Dermatology

News

telemedicine
News
Type 2 Inflammation and Fibrotic Pathways Drive Localized Scleroderma
02/24/2025
Riya Gandhi, MA
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct...
02/24/2025
APP Institute Dermatology
contact dermtitis + Neck + Eczema + rash
News
Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis
02/14/2025
Riya Gandhi, MA
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad...
02/14/2025
APP Institute Dermatology
SOC
News
Immune Triggers Linked to Chronic Pruritus and Elevated Type 2 Inflammation
01/29/2025
Riya Gandhi, MA
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of...
01/29/2025
APP Institute Dermatology
Atopic dermatitis
News
Dupilumab Linked to Lower Risk of Upper Respiratory Infections in Patients With Atopic Dermatitis
01/17/2025
Riya Gandhi, MA
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Atopic dermatitis
News
New Screening Tool Promotes Multidisciplinary Approach to Type 2 Inflammation-Related Diseases
01/07/2025
Riya Gandhi, MA
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
APP Institute Dermatology
telemedicine
News
Type 2 Inflammation and Fibrotic Pathways Drive Localized Scleroderma
02/24/2025
Riya Gandhi, MA
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct inflammatory and fibrotic signatures in localized scleroderma, highlighting the role of adaptive immunity and potential therapeutic targets.
A new study reveals distinct...
02/24/2025
APP Institute Dermatology
contact dermtitis + Neck + Eczema + rash
News
Dupilumab Therapy Reduces Systemic Inflammation in Prurigo Nodularis
02/14/2025
Riya Gandhi, MA
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad anti-inflammatory effects of dupilumab in prurigo nodularis, with potential implications for addressing systemic disease comorbidities.
A study highlights the broad...
02/14/2025
APP Institute Dermatology
SOC
News
Immune Triggers Linked to Chronic Pruritus and Elevated Type 2 Inflammation
01/29/2025
Riya Gandhi, MA
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of immune triggers, including vaccines and therapies, in chronic pruritus and its association with heightened type 2 inflammation markers.
New findings uncover the role of...
01/29/2025
APP Institute Dermatology
Atopic dermatitis
News
Dupilumab Linked to Lower Risk of Upper Respiratory Infections in Patients With Atopic Dermatitis
01/17/2025
Riya Gandhi, MA
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the safety benefits of dupilumab over traditional immunosuppressants in reducing upper respiratory infection risks for patients with moderate-to-severe atopic dermatitis.
New research highlights the...
01/17/2025
APP Institute Dermatology
Atopic dermatitis
News
New Screening Tool Promotes Multidisciplinary Approach to Type 2 Inflammation-Related Diseases
01/07/2025
Riya Gandhi, MA
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire aims to address the unmet need for timely detection and referral of coexisting type 2 inflammation-related diseases, bridging gaps in interdisciplinary care.
A groundbreaking questionnaire...
01/07/2025
APP Institute Dermatology

Quiz

Atopic dermatitis
Quiz
Barrier Repair & Inflammation Control in Atopic Dermatitis
03/23/2025
Riya Gandhi, MA
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how...
03/23/2025
APP Institute Dermatology
Rash
Quiz
Environmental Triggers of Barrier Damage & Type 2 Inflammation
03/12/2025
Riya Gandhi, MA
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how...
03/12/2025
APP Institute Dermatology
Atopic dermatitis
Quiz
Understanding Type 2 Inflammation: Pathways and Treatment Options
02/07/2025
Riya Gandhi, MA
Test your knowledge of type 2 Inflammation and your understanding of its pathways and treatment options.
Test your knowledge of type 2 Inflammation and your understanding of its pathways and treatment options.
Test your knowledge of type 2...
02/07/2025
APP Institute Dermatology
Atopic dermatitis
Quiz
Barrier Repair & Inflammation Control in Atopic Dermatitis
03/23/2025
Riya Gandhi, MA
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how barrier dysfunction, Staph aureus, and type 2 inflammation fuel atopic dermatitis.
Test your knowledge on how...
03/23/2025
APP Institute Dermatology
Rash
Quiz
Environmental Triggers of Barrier Damage & Type 2 Inflammation
03/12/2025
Riya Gandhi, MA
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how pollution, detergents, and food additives contribute to barrier damage, type 2 inflammation, and food allergies.
Test your knowledge on how...
03/12/2025
APP Institute Dermatology
Atopic dermatitis
Quiz
Understanding Type 2 Inflammation: Pathways and Treatment Options
02/07/2025
Riya Gandhi, MA
Test your knowledge of type 2 Inflammation and your understanding of its pathways and treatment options.
Test your knowledge of type 2 Inflammation and your understanding of its pathways and treatment options.
Test your knowledge of type 2...
02/07/2025
APP Institute Dermatology
APP Institute Dermatology

 

The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of patient care across the spectrum of dermatology.

The APP Institute | Dermatology is designed for Advanced Practice Providers who specialize in Dermatology, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with Dermatology. Engage year-round with the Dermatology Learning Network to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.

August 16-17 | Complimentary Virtual Event | Register Now

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use